Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
14.68
-0.81 (-5.23%)
At close: Jun 05, 2025, 3:59 PM
15.18
3.41%
After-hours: Jun 05, 2025, 07:16 PM EDT

Cadrenal Therapeutics Common Stock Statistics

Share Statistics

Cadrenal Therapeutics Common Stock has 1.97M shares outstanding. The number of shares has increased by -88.26% in one year.

1.97M
-88.26%
5.45%
n/a
n/a
2,569
10.27%

Short Selling Information

The latest short interest is 51.44K, so 2.62% of the outstanding shares have been sold short.

51.44K
2.62%
3.5%
1.72

Valuation Ratios

The PE ratio is -1.66 and the forward PE ratio is -4.56. Cadrenal Therapeutics Common Stock's PEG ratio is 0.18.

-1.66
-4.56
0
n/a
2.38
-2.4
0.18
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cadrenal Therapeutics Common Stock.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.

3.77
3.77
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-2,662,842
4
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 95.42% in the last 52 weeks. The beta is 1.12, so Cadrenal Therapeutics Common Stock's price volatility has been higher than the market average.

1.12
95.42%
15.83
15.09
53.61
25,003

Income Statement

n/a
n/a
-10.96M
-10.65M
-10.65M
-10.65M
-8.73
Full Income Statement

Balance Sheet

The company has 10.02M in cash and 0 in debt, giving a net cash position of 10.02M.

10.02M
n/a
n/a
-25.72M
7.95M
6.1M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.36M and capital expenditures -6.54K, giving a free cash flow of -7.36M.

-7.36M
-6.54K
-7.36M
-6.04
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CVKD is $32, which is 114% higher than the current price. The consensus rating is "Buy".

$32
114%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Aug 20, 2024. It was a backward split with a ratio of 1:15.

Aug 20, 2024
backward
1:15

Scores

-0.73
0